中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Structural insights into the human D1 and D2 dopamine receptor signaling complexes

文献类型:期刊论文

作者Zhuang, Youwen1,2; Xu, Peiyu1,2,3,4; Mao, Chunyou3,4,5,6; Wang, Lei7; Krumm, Brian8; Zhou, X. Edward9; Huang, Sijie1,2,10; Liu, Heng7; Cheng, Xi1,11; Huang, Xi-Ping8
刊名CELL
出版日期2021-02-18
卷号184期号:4页码:931-+
ISSN号0092-8674
DOI10.1016/j.cell.2021.01.027
通讯作者Roth, Bryan L.(bryan_roth@med.unc.edu) ; Zhang, Yan(zhang_yan@zju.edu.cn) ; Zhang, Cheng(chengzh@pitt.edu) ; Xu, H. Eric(eric.xu@simm.ac.cn)
英文摘要The D1- and D2-dopamine receptors (D1R and D2R), which signal through G(s) and G(i), respectively, represent the principal stimulatory and inhibitory dopamine receptors in the central nervous system. D1R and D2R also represent the main therapeutic targets for Parkinson's disease, schizophrenia, and many other neuropsychiatric disorders, and insight into their signaling is essential for understanding both therapeutic and side effects of dopaminergic drugs. Here, we report four cryoelectron microscopy (cryo-EM) structures of D1R-G(s) and D2R-G(i) signaling complexes with selective and non-selective dopamine agonists, including two currently used anti-Parkinson's disease drugs, apomorphine and bromocriptine. These structures, together with mutagenesis studies, reveal the conserved binding mode of dopamine agonists, the unique pocket topology underlying ligand selectivity, the conformational changes in receptor activation, and potential structural determinants for G protein-coupling selectivity. These results provide both a molecular understanding of dopamine signaling and multiple structural templates for drug design targeting the dopaminergic system.
资助项目National Key R&D Programs of China[2018YFA0507002] ; National Key R&D Programs of China[2019YFA0508800] ; Shanghai Municipal Science and Technology Major Projects[2019SHZDZX02] ; CAS Strategic Priority Research Program[XDB37030103] ; National Natural Science Foundation of China[81922071] ; National Natural Science Foundation of China[31770796] ; Zhejiang Province Natural Science Fund for Excellent Young Scholars[LR19H310001] ; Fundamental Research Funds for the Central Universities[2019XZZX001-01-06] ; Science and Technology Commission of Shanghai Municipality[20431900100] ; Jack Ma Foundation[2020-CMKYGG-05] ; National Science and Technology Major Projects[2018ZX09711002-002-002] ; NIMH (Psychoactive Drug Screening Program)[RO1MH112205] ; NIH[R35GM128641]
WOS研究方向Biochemistry & Molecular Biology ; Cell Biology
语种英语
WOS记录号WOS:000629633400010
出版者CELL PRESS
源URL[http://119.78.100.183/handle/2S10ELR8/295411]  
专题新药研究国家重点实验室
通讯作者Roth, Bryan L.; Zhang, Yan; Zhang, Cheng; Xu, H. Eric
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
2.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
3.Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Biophys, Sch Med, Hangzhou 310058, Peoples R China
4.Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pathol, Sch Med, Hangzhou 310058, Peoples R China
5.Zhejiang Univ, Zhejiang Lab Syst & Precison Med, Med Ctr, Hangzhou 311121, Peoples R China
6.Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou 310058, Peoples R China
7.Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA
8.Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
9.Van Andel Res Inst, Ctr Canc & Cell Biol, Program Struct Biol, Grand Rapids, MI USA
10.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
推荐引用方式
GB/T 7714
Zhuang, Youwen,Xu, Peiyu,Mao, Chunyou,et al. Structural insights into the human D1 and D2 dopamine receptor signaling complexes[J]. CELL,2021,184(4):931-+.
APA Zhuang, Youwen.,Xu, Peiyu.,Mao, Chunyou.,Wang, Lei.,Krumm, Brian.,...&Xu, H. Eric.(2021).Structural insights into the human D1 and D2 dopamine receptor signaling complexes.CELL,184(4),931-+.
MLA Zhuang, Youwen,et al."Structural insights into the human D1 and D2 dopamine receptor signaling complexes".CELL 184.4(2021):931-+.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。